| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2020: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2019: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Outline of Final Research Achievements |
Stroke thrombectomy has been established as a standard of care. In contrary, post-thrombectomy subarachnoid hemorrhages (SAH) have been observed which were not seen after medical treatment. This study found that post-thrombectomy SAH occurred in 7.2% of patients and was not associated with a favorable outcome. Post-thrombectomy SAH was positively associated with CT angiography and the puncture-to-reperfusion time and negatively associated with blood glucose levels and complete recanalization). In addition, although the rate of complete recanalization and the rate of a favorable outcome decreased year by year, there was no trend of rates of intracranial hemorrhage including SAH. The number of thrombectomied patients and the rate of favorable outcome did not decrease during the COVID-19 epidemic period (the year 2020) as well as no significant association was found between the COVID-19 period and the incidence of post-thrombectomy SAH.
|
